Introduction {#Sec1}
============

The clinical presentation of acute pancreatitis (AP) ranges from mild edematous to severe acute necrotizing pancreatitis (SAP) \[[@CR1]\]. Edematous pancreatitis usually resolves without major consequences, whereas SAP is associated with considerable morbidity and mortality \[[@CR1]\]. The death rate has significantly decreased over time, from 60 to 80 %, during the early 20th century, to 20--30 % in recent years \[[@CR1]--[@CR4]\]. Still, prediction of the clinical course of these patients remains challenging. Several models are used to stratify the severity of the disease at presentation \[[@CR5]--[@CR9]\], but they lack sufficient predictive granularity \[[@CR10], [@CR11]\]. One of the reasons for this limitation is the fact that they may not capture all of the relevant preexisting medical and physiological conditions that might influence patients' prognosis \[[@CR11]\].

With the increasing prevalence of obesity \[[@CR12]--[@CR18]\], there is growing evidence that obese patients with SAP might have worse outcomes in comparison to patients with normal body mass index (BMI) \[[@CR19]--[@CR24]\]. The higher mortality of obese patients is thought to be due to the additive effect of more extensive fat necrosis \[[@CR25]\], chronic up-regulation of the inflammatory response \[[@CR26]\], and subsequent increased risk of multiorgan failure (MOF) and abdominal compartment syndrome (ACS) \[[@CR22]\]. However, further studies are necessary, because some authors have failed to confirm these findings and found no differences between obese and nonobese patients \[[@CR22], [@CR25]--[@CR27]\]. Studies on clinical outcomes of patients admitted to the ICU for SAP are scarce, and only a few investigated the role of obesity in the development of ACS. In addition, there is a lack of studies to evaluate the performance of scoring systems to predict the development of ACS in the presence of SAP.

In view of these limitations, the primary purpose of this study was to test the null hypothesis for in-hospital mortality and the development of ACS between obese and nonobese patients affected by SAP and admitted to the ICU. Secondary goals were: to evaluate the incidence of ACS, to examine risk factors for ACS, to assess the outcomes of patients undergoing decompressive laparotomy (DL), and to investigate the performance of validated scoring systems (e.g., Ranson, APACHE II, Glasgow-Imrie Scale, SOFA) and selected patients' characteristics (e.g., age, BMI, gender, number of comorbidities) to predict ACS and in-hospital mortality.

Patients and methods {#Sec2}
====================

Study design {#Sec3}
------------

A cohort of patients affected by SAP was retrospectively identified at the Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia (Canada). All patients admitted to the ICU between July 1, 2005 and June 30, 2009 were screened for eligibility according to the study protocol approved by the local ethics review board (ERB). The International Classification of Diseases Version 9 (ICD-9) code 577.0 was used to identify patients with SAP from a prospectively maintained electronic database. The diagnosis of AP was confirmed by threefold elevation of serum amylase and lipase levels during the 72 h period preceding their admission to the ICU. For each patient, the following variables were collected: age, gender, body weight, height, number of comorbidities (ICD-9 codes), date of admission and discharge from ICU, development of ACS, intra-abdominal pressures measured in patients with suspected IAH, need for DL, time interval from diagnosis of ACS to DL, surgical technique used to manage the laparostomy site, postoperative abdominal wall complications, and overall mortality rate.

Severity of AP at the time of ICU admission was determined by validated prognostic models: Acute Physiology and Chronic Health Evaluation II score (APACHE-II; range 0--67) \[[@CR28], [@CR29]\], Glasgow Scale (GS; range 0--8), Sepsis-related Organ Failure Assessment score (SOFA; range 0--24) \[[@CR8]\], Ranson score (range 0--11) \[[@CR5], [@CR30]\], and Charlson Comorbidity Index (CCI) (range 0--36) \[[@CR31], [@CR32]\]. Predicted mortality of the study population was calculated by using normograms or validated logistic equations of both Ranson criteria and APACHE-II scores \[[@CR33], [@CR34]\].

Sample size calculation {#Sec4}
-----------------------

Sample size calculation was based on the estimated ICU mortality of nonobese patients that in previous studies was reported to be up to 30 % \[[@CR1]--[@CR3]\]. The expected mortality of obese patients was estimated by doubling the death rate of normal weight individuals affected by SAP as published in a recent meta-analysis \[[@CR21]\]. Using these premises, a total number of 42 subjects were needed to reach a power of 0.8 with a two-tail alpha level of 0.05.

Inclusion and exclusion criteria {#Sec5}
--------------------------------

Patients included in this study satisfied the following criteria: adult age (older than 18 years), a primary diagnosis of SAP by the Atlanta criteria \[[@CR35], [@CR36]\] and requiring admission to ICU for at least one of the following conditions: hypotension, renal failure, respiratory insufficiency, cardiac dysfunction, disseminated intravascular coagulation, or gastrointestinal hemorrhage \[[@CR37]\].

Exclusion criteria were: pregnant women, patients younger than 18 years, diagnosis of acute or chronic pancreatitis, recent traumas, or surgical interventions responsible for the development of AP.

Definitions {#Sec6}
===========

Severity of acute pancreatitis {#Sec7}
------------------------------

SAP was defined as AP in the context of new onset of organ failure and/or local complications according to the revised Atlanta classification of AP \[[@CR35], [@CR36]\] \_ENREF_37. Patients with SAP were defined as affected by at least one organ failure that lasted more than 48 h or who developed complications leading to death.

On the first day of admission to ICU, the severity of AP was measured by utilizing the Glasgow-Imrie score \[[@CR6]\], the APACHE II \[[@CR7]\], and the SOFA \[[@CR8]\] scores. A fourth prognostic model, the Ranson score \[[@CR5]\], was calculated by the combination of patients' age, laboratory, and clinical variables obtained at the time of hospital admission and 48 h later. Predicted mortality rate of the study population was calculated by using the Ranson score and the adjusted APACHE II logistic regression model \[[@CR34]\]:$$\documentclass[12pt]{minimal}
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Calculations were performed by accessing the on line calculator available at the Societe' Francoise d'Anesthesie et de Ranimation webpage \[[@CR38]\].

Abdominal compartment syndrome {#Sec8}
------------------------------

Abdominal compartment syndrome was defined as the presence of intra-abdominal pressure equal or higher than 20 mmHg in association with acute organ failure \[[@CR39]\]. Intraperitoneal pressure was measured by inserting a standard Foley urinary catheter of at least 16 Fr into the patient's bladder, which was then filled with 25--30 mL of saline solution. Measurements of the intra-abdominal pressure were obtained at the end of the expiration and with the patients in supine position \[[@CR40]\] by connecting the Foley catheter to a digital pressure transducer after clamping its outflow channel. The pubic symphysis was considered the reference level \[[@CR41]\].

Alternatively, ACS was diagnosed during clinical examinations when patients experienced severe abdominal distension and at least one of these other conditions: (1) tachycardia and/or hypotension despite elevation of the central venous pressure (CVP), (2) tachypnea and/or elevated peak inspiratory pressures when on ventilator support with refractory hypoxemia and/or hypercapnia, (3) renal dysfunction not responsive to intravenous diuretics or dopamine infusion \[[@CR40]\].

Obesity {#Sec9}
-------

Body mass index (BMI; Kg/m^2^) ≥30 was used as a cutoff point to identify obese patients according to the definition proposed by the World Health Organization \[[@CR11]\].

Decompressive laparotomy {#Sec10}
------------------------

Decompressive laparotomy was defined as any surgical intervention designed to reinstitute the physiological abdominal wall compliance. This was obtained by interrupting the skin, fascia, and peritoneum along a midline abdominal incision extending from the xiphoid process of the sternum to the suprapubic area in combination with the anterior wall muscles if necessary \[[@CR42]\]. During DL, the intra-abdominal organs were inspected and released from the tension of the enclosed cavity until a satisfactory cardiopulmonary response was obtained. All patients underwent exposure of edematous intestinal loops, omentum, and solid organs, and none was treated by subcutaneous linea alba fasciotomy or transverse laparostomy \[[@CR40], [@CR43], [@CR44]\]. Intraperitoneal drains were placed at the discretion of the surgeons and no pancreatic debridement was performed during DL.

Temporary abdominal closure {#Sec11}
---------------------------

Temporary abdominal closure was defined as any technique used to close the abdominal cavity provisionally by creating a laparostomy that allowed decompression of the intraperitoneal organs but preventing their contamination, hypothermia, and fluid losses \[[@CR45]\]. Available techniques for the provisional abdominal wall closure were: (1) placement of absorbable mesh material consisting of polyglactin 910 (Vicrlyl-mesh, Ethicon^®^) or polyglicolic acid (Dexon-mesh, Dexon^®^) \[[@CR46], [@CR47]\], (2) coverage of the intra-abdominal organs with expanded polytetrafluoroethylene (ePTFE) foils \[[@CR48], [@CR49]\] or adhesive (Opsite plastic dressing, 3 M, Tegaderm^®^) and nonadhesive plastic layer derived from irrigation bags (e.g., Bogota-bag) \[[@CR49], [@CR50]\], and (3) combining adhesive plastic foils with a polygalactin sponge (V.A.C KCL^®^) and delivering a constant negative pressure of 100--150 mmHg applied via tubes connected to a computerized portable vacuum device \[[@CR51]--[@CR53]\].

Length of hospital stay and mortality {#Sec12}
-------------------------------------

Hospital stay was defined as the number of days that each patient spent at the tertiary medical centre. All causes of mortality during this period of time were considered direct consequences of SAP. Deaths that might have occurred after the patients were discharged home or to rehabilitation centers or to long-term facilities were not measured as not traceable by the investigators.

Statistical analysis {#Sec13}
====================

Summary statistics were constructed for the baseline values, using frequencies and proportions for categorical data, and mean and standard deviation (SD) for continuous variables. Categorical outcomes were analyzed by using chi-square test or Fisher's exact test when appropriate. Continuous variables were compared by using Mann--Whitney or Kruskal--Wallis test. Univariate logistic analysis also was preformed to look for possible associations with morbidity, mortality, and the development of ACS (age, obesity, number of comorbidities, Ranson score, SOFA score, Glasgow-Imrie score, APACHE II score). Multivariable logistic regression analyses were performed using step-wise techniques to explore predicting factors for the development of ACS and mortality. The stepwise procedure was set at the threshold of 0.1 for inclusion and 0.05 for exclusion. Discrimination was analyzed as the capacity of prognostic models or clinical parameters to distinguish high-risk from low-risk individuals for hospital mortality and development of ACS. Discrimination of predicting factors was then assessed by Receiver Operating Characteristic (ROC) curves. Excellent discrimination was defined if the area under the curve (AUC) of ROC was ≥0.8, good discrimination was defined when the AUC was between 0.7 and 0.8 and poor discrimination when the AUC was \<0.7. ROC curves were compared to the reference line associated with AUC = 0.5. Statistical analysis was performed by using SPSS^®^ software (Version 19, SPSS, Inc., Chicago, IL), and all tests were two-tailed and considered significant when *P* \< 0.05.

Results {#Sec14}
=======

Study cohort {#Sec15}
------------

During a 4-year period, a total of 72 patients were admitted to ICU with the diagnosis of AP. After reviewing their medical files, 27 subjects were excluded, because they failed to satisfy the revised Atlanta criteria for SAP published in 2008 \[[@CR35], [@CR36]\] as their organ failure resolved within 48 h. The remaining 45 patients represented the study population and their demographic and clinical characteristics are summarized in Table [1](#Tab1){ref-type="table"}. Mean time from hospital admission to ICU admission was 3.8 days.Table 1Patients' characteristics and clinical variables at admission to ICU and 48 h later for calculation of Ranson score (total patients = 45)VariableValueDemographic Age, year (mean, SD)59 (13.3) Male gender (no. patients, %)36 (80)Hospital mortality (no. patients, %)11 (24.4)Length of overall hospital stay, days (mean, SD)85.9 (107.8)Etiology of pancreatitis (no. patients, %) Gallstone24 (53.3) Alcohol12 (26.7) Idiopathic7 (15.6) Postendoscopic cholangiopancreatography (ERCP)2 (4.4)Clinical variables at admission to ICU BMI (mean, SD)30.6 (5.2) Obesity (BMI \> 30) (no. patients, %)24 (53) Body temperature, Celsius (mean, SD)37.8 (0.7) Heart rate/min (mean, SD)111.5 (19.3) Systolic blood pressure, mmHg (mean, SD)128.4 (20.1) Diastolic blood pressure, mmHg (mean, SD)68.2 (13.6) Respiratory rate/min (mean, SD)19.7 (8.9)Laboratory variables at admission to ICU White blood cells, 10^3^/μL (mean, SD)14.9 (4.5) Platelets, 10^3^/μL (mean, SD)221.4 (139) Creatinine, μmol/L (mean, SD)217.7 (160) Glucose, mmol/L (mean, SD)8.9 (4.4) LDH, U/L (mean, SD)479.3 (335.8) AST, U/L (mean, SD)90.4 (74.3) Arterial pH (mean, SD)7.3 (0.1) Alveolar arterial gradient (A-a gradient) (mean, SD)288.2 (164.3) Pulmonary artery oxygen/FiO~2~ ratio (mean, SD)182.5 (82.2)Laboratory variables at 48 h after admission to ICU Serum calcium, mmol/L (mean, SD)2.1 (0.1) Blood urea nitrogen, mmol/L (mean, SD)13.6 (8.3) Sequestration of more than 6 L in 48 h (no. patients, %)44 (97.8) Blood urea nitrogen increase at least by 1.8 (no. patients, %)26 (59.1) PaO~2~ \<60 mmHg within 48 h (no. patients, %)12 (26.7) Hematocrit fall \>10 % (no. patients, %)43 (95)CCI at admission to ICU (mean, SD)2.8 (2)Severity of acute pancreatitis at admission to ICURanson score (mean, SD)5.4 (1.7)Glasgow-Imrie scale (mean, SD)9.1 (4)APACHE II score (mean, SD)20.3 (6.4)Sequential Organ Failure Assessment (mean, SD)8.5 (3)Abdominal compartment syndrome (no. patients, %)16 (35.5)*ERCP* endoscopic retrograde cholangiopancreatography, *BMI* body mass index, *LDH* lactic dehydrogenase, *AST* aspartate transaminase, *CCI* Charlson Comorbidity Index

Obesity, morbidity, mortality, and decompressive laparotomy {#Sec16}
-----------------------------------------------------------

Obesity was observed in 24 (53 %) patients who had clinical presentation, disease severity, and demographic characteristics similar to patients with lower BMI but significantly lower in-hospital mortality: 12.5 versus 38 % (*P* = 0.04; Table [2](#Tab2){ref-type="table"}). Urgent DL was performed in 41 % of obese patients, whereas in only 28 % of nonobese patients (*P* = 0.533). Obese patients who underwent DL had similar clinical presentation and overall outcomes to nonobese individuals except that they experienced more postoperative incisional hernias (70 vs. 16 %; *P* = 0.039; Table [3](#Tab3){ref-type="table"}).Table 2Characteristics of obese patients (BMI ≥ 30) versus nonobese patientsVariableBMI ≥ 30 (*n* = 24)BMI \< 30 (*n* = 21)*P* valueDemographic Age, year (mean, SD)58.5 (13.9)60.4 (12.8)0.063 Male gender (no. patients, %)19 (79.1)17 (80.1)0.88Hospital mortality (no. patients, %)3 (12.5)8 (38.0)**0.046**Length of overall hospital stay, days (mean, SD)110.7 (136.8)57.7 (49.8)0.087Etiology of pancreatitis (no. patients, %) Gallstone12 (50.0)12 (57.1)0.218 Alcohol8 (33.3)4 (19.0) Idiopathic2 (8.3)5 (23.8) Postendoscopic Cholangiopancreatography (ERCP)2 (8.3)0Use of parenteral antibiotics for prophylaxis (no. patients, %)22 (91.6)17 (80.9)0.396Clinical variables at admission to ICU BMI (mean, SD)34.1 (4.3)26.6 (2.5)**0.0001** Body temperature, Celsius (mean, SD)37.9 (0.77)37.6 (0.76)0.168 Heart rate/min (mean, SD)108.1 (20.2)115.4 (17.9)0.209 Systolic blood pressure, mmHg (mean, SD)128.0 (17.0)129.0 (23.8)0.869 Diastolic blood pressure, mmHg, (mean, SD)67.2 (12.5)69.5 (15.1)0.583 Respiratory rate/min (mean, SD)19.8 (8.3)19.7 (9.7)0.965Laboratory variables at admission to ICU White blood cells, 10^3^/μL (mean, SD)15.1 (4.9)14.7 (4.1)0.327 Platelets, 10^3^/μL (mean, SD)228.6 (177.3)213.1 (78.6)0.715 Creatinine, μmol/L (mean, SD)249.6 (169.5)181.2 (143.7)0.155 Glucose (mmol/L) (mean, SD)8.8 (3.4)9.0 (5.3)0.882 LDH, U/L (mean, SD)521.5 (400.4)431.1 (243.0)0.373 AST, U/L (mean, SD)100.3 (86.9)79.2 (56.5)0.348 Arterial pH (mean, SD)7.31 (0.08)7.35 (0.11)0.223 Alveolar arterial gradient (A-a gradient), (mean, SD)313.11 (180.1)260.0 (143.1)0.285 Pulmonary artery oxygen/FiO~2~ ratio (mean, SD)111.5 (52.9)95.8 (58.4)0.35Laboratory variables at 48 h after admission to ICU Serum calcium (mmol/L) (mean, SD)2.1 (0.2)2.1 (0.1)0.836 Blood urea nitrogen (mmol/L) (mean, SD)15.2 (9.4)12.0 (6.6)0.205 Sequestration of more than 6 L in 48 h (no. patients, %)24 (100)20 (95.2)0.28 Blood urea nitrogen increase at least by 1.8 (no. patients, %)15 (62.5)11 (52.3)0.387 PaO~2~ \<60 mmHg within 48 h (no. patients, %)6 (25)6 (28.5)0.787 Hematocrit fall \>10 % (no. patients, %)23 (95.8)20 (95.2)0.923CCI at admission to ICU (mean, SD)2.7 (1.9)3.0 (2.1)0.531Severity of acute pancreatitis at admission to ICURanson score system5.6 (1.9)5.1 (1.5)0.373Glasgow scale8.1 (4.6)10.1 (3.0)0.098APACHE II score (mean, SD)22.0 (7.0)18.3 (5.0)0.053Sequential Organ Failure Assessment (mean, SD)9.3 (3.3)7.6 (2.5)0.067Decompressive laparotomy (no. patient, %)10 (41.6)6 (28.5)0.533Bold indicate statistical significant values*ERCP* endoscopic retrograde cholangiopancreatography, *BMI* body mass index, *LDH* lactic dehydrogenase, *AST* aspartate transaminase, *ICU* intensive care unitTable 3Summary of clinical characteristics, early and late management of the open abdomen after decompressive laparotomy in obese (BMI ≥ 30) and nonobese patientsVariableBMI ≥ 30 (*n* = 10)BMI \< 30 (*n* = 6)*P* valueIntra-abdominal pressure, mmHg (bladder pressure measurement, mean, SD)26.7 (9.3)32.3 (15.2)0.361Patients with bladder pressure ≥20 mmHg (no. patients, %)8 (80)5 (83.3)0.482Clinical presentation of ACS (no. patients, %) Abdominal distension with acute renal failure4 (40)1 (16.6)0.588 Abdominal distension with acute respiratory failure6 (60)5 (83.3) Time between diagnosis of ACS and surgical decompression, hr (mean, SD)3.3 (1.7)2.8 (1.7)0.638Early management of abdominal incision (no. patients, %) Bogota bag7 (70)4 (66.6)0.889 Wound VAC system3 (30)2 (33.3)Late management of abdominal incision (no. patients, %) Delayed primary abdominal wall closure6 (60)5 (83.3)0.33 Use of split-thickness skin graft3 (30)00.137 Death before abdominal incision closure1 (10)1 (16.6)0.761Abdominal complication after decompressive laparotomy (no. patients, %) Pancreatico-cutaneous fistula1 (10)2 (33.3)0.247 Entero-cutaneous / entero-atmospheric fistula5 (50)2 (33.3)0.515 Incisional infection8 (80)2 (33.3)0.062 Wound dehiscence3 (30)00.137 Incisional hernia7 (70)1 (16.6)**0.039**In-hospital mortality (no. patients, %)1 (10)2 (33.3)0.252Bold indicate statistical significant values

In-hospital mortality {#Sec17}
---------------------

Among all 45 patients, 11 (24.4 %) died from complications of SAP (Table [4](#Tab4){ref-type="table"}). Univariate analysis showed that mortality was associated with older age (*P* = 0.001), lower systolic blood pressure at admission to ICU (*P* = 0.05), and higher number of comorbidities (*P* = 0.001). Predicted mortality by Ranson criteria and by APACHE II score for the entire cohort were 41 % (SD = 30.2) and 38.3 % (SD = 19.4), respectively. Comparison between observed (24 %) and predicted (38--41 %) mortality by APACHE II Score of the entire cohort was clinically but not statistically significant (*P* = 0.175).Table 4Characteristics of patients who died versus patients who survived severe acute pancreatitisVariablePatients who died (*n* = 11)Patients who survived (*n* = 34)*P* valueDemographic Age, year (mean, SD)70.9 (11.9)55.7 (11.6)**0.001** Male gender (no. patients, %)9 (81.8)27 (79.4)0.78Etiology of pancreatitis (no. patients, %) Gallstone9 (81.8)15 (44.1)0.176 Alcohol1 (9)11 (32.3) Idiopathic1 (9)6 (17.6) Postendoscopic cholangiopancreatography (ERCP)02 (5.8)Length of overall hospital stay, days (mean, SD)25 (21.9)105.7 (117.1)**0.017**Clinical variables on admission to ICU BMI (mean, SD)28.6 (3.1)31.2 (5.6)0.128 Obesity (BMI \> 30) (no. patients, %)3 (27.2)21 (61.7)0.08 Body temperature, Celsius (mean, SD)37.5 (0.7)37.8 (0.7)0.199 Heart rate/min (mean, SD)112.0 (19.2)111.4 (19.6)0.921 Systolic blood pressure, mmHg (mean, SD)117.6 (19.3)131.8 (19.4)**0.05** Diastolic blood pressure, mmHg (mean, SD)64.7 (9)69.4 (14.7)0.348 Respiratory rate/min (mean, SD)20.7 (10.6)19.4 (8)0.68 Bladder pressure measurement, mmHg (mean, SD)22.7 (5.1)30.8 (12.7)0.24Laboratory variables on admission to ICU White blood cells, 10^3^/μL (mean, SD)13.7 (3.7)15.3 (4.7)0.31 Platelets, 10^3^/μL (mean, SD)217.5 (80.1)222.6 (154.2)0.91 Creatinine, μmol/L (mean, SD)211.0 (126.4)219.9 (171)0.87 Glucose, mmol/L (mean, SD)11.0 (6.9)8.3 (3)0.069 LDH, U/L (mean, SD)326.3 (113.4)528.8 (368.9)0.082 AST, U/L (mean, SD)67.2 (34.8)98.0 (82.1)0.237 Arterial pH (mean, SD)7.30 (0.92)7.34 (0.1)0.354 Alveolar arterial gradient (A-a gradient) (mean, SD)261.1 (105.3)297.1 (179.7)0.531 Pulmonary artery oxygen/FiO~2~ ratio (mean, SD)117.7 (58.9)99.7 (54.5)0.357Laboratory variables at 48 h after admission to ICU Serum calcium, mmol/L (mean, SD)2.1 (0.2)2.1 (0,.17)0.64 Blood urea nitrogen, mmol/L (mean, SD)12.5 (2.4)14.0 (9.3)0.641 Sequestration of more than 6 L in 48 h (no. patients, %)11 (100)33 (97)1 Blood urea nitrogen increase at least by 1.8 (no. patients, %)7 (63.6)19 (55.8)0.489 PaO~2~ \<60 mmHg within 48 h (no. patients, %)3 (27.2)9 (26.4)1 Hematocrit fall \>10 % (no. patients, %)3 (27.2)9 (26.4)1CCI at admission to ICU (mean, SD)2.3 (1.7)4.5 (2)**0.001**Severity of acute pancreatitis on admission to ICU Ranson score system5.63 (1.9)5.38 (1.9)0.683 Glasgow scale10.1 (1.9)8.7 (4.5)0.324 APACHE II score (mean, SD)20.6 (4.6)20.2 (6.9)0.87 Sequential Organ Failure Assessment (mean, SD)8.6 (2.2)8.5 (3.3)0.921Decompressive laparotomy (no. patients, %)4 (36.3)12 (35.2)1.00Early management of abdominal incision (no. patients, %) Bogota bag2 (18.1)9 (26.4)0.547 Wound VAC system2 (18.1)3 (8.8)Late management of abdominal incision (no. patients, %) Delayed primary abdominal wall closure3 (27.2)8 (23.5)1 Use of split-thickness skin graft03 (8.8)0.529Complication after abdominal wall closure (no. patients, %) Pancreatico-cutaneous fistula03 (8.8)0.529 Entero-cutaneous fistula1 (9.0)6 (17.6)0.585 Incisional infection19 (26.4)0.118 Wound dehiscence12 (5.8)1 Incisional hernia17 (20.5)0.569Bold indicate statistical significant values*ERCP* endoscopic retrograde cholangiopancreatography, *BMI* body mass index, *LDH* lactic dehydrogenase, *AST* aspartate transaminase, *ICU* intensive care unit, *CCI* Charlson Comorbidity Index

Univariate logistic regression analysis showed that age was a significant predictor of in-hospital mortality for the entire cohort (odds ratio (OR) 1.159; 95 % CI = 1.043--1.288; *P* = 0.006) and more so for obese patients (OR 1.191; 95 % CI = 1.012--1.401; *P* = 0.035; Table [5](#Tab5){ref-type="table"}). After adjusting for the severity of the disease by Ranson, SOFA, APACHE II and Glasgow-Imrie scores, obesity status, and development of ACS, the only significant predictor for in-hospital mortality in the study population was patients' age (OR 1.273; 95 % CI = 1.052--1.541; *P* = 0.013).Table 5Univariate logistic regression: risk factors for in-hospital mortalityVariableOR for entire study population (95 % CI)*P* valueOR for obese patients (95 % CI)*P* valueOR for nonobese patients (95% CI)*P* valueAge (year)1.159 (1.043, 1.288)**0.006**1.191 (1.012, 1.401)**0.035**1.134 (0.99, 1.298)0.069Systolic blood pressure (mmHg)0.956 (0.913, 1.002)0.0580.966 (0.895, 1.044)0.9660.051 (0.896, 1.01)0.103Obesity (BMI [\> ]{.ul}30)4.308 (0.965, 19.236)0.056**--------**Abdominal compartment syndrome0.955 (0.232, 3.932)0.949**--------**Charlson Comorbidity score1.845 (1.199, 2.84)**0.005**3.782 (1.06, 13.489)**0.04**1.518 (0.929, 2.483)0.096Ranson score1.085 (0.749, 1.591)0.6760.789 (0.376, 1.654)0.531.761 (0.872, 3.555)0.114SOFA score1.012 (0.808, 1.267)0.3181.164 (0.782, 1.733)0.4541.057 (0.739, 1.513)0.761APACHE II score1.009 (0.907, 1.124)0.8661.06 (0.875, 1.283)0.5531.061 (0.882, 1.277)0.529Glasgow-Imrie score1.095 (0.917, 1.307)0.9191.106 (0.842, 1.453)0.471.011 (0.75, 1.362)0.942Bold indicate statistical significant values

Receiver operator characteristic (ROC) curves for in-hospital mortality for ICU patients with SAP showed that both age and the number of comorbidities had excellent discrimination with AUC measuring 0.846 (95 % CI = 0.7--0.99; *P* = 0.001) and 0.801 (95 % CI = 0.633--0.968; *P* = 0.003), respectively (Fig. [1](#Fig1){ref-type="fig"}). On the other hand, established predictive models (Ranson, Glasgow-Imrie, SOFA, APACHE II) had low discrimination with AUC ranging from 0.5 (APACHE II) to 0.584 (Ranson).Fig. 1Receiver operating characteristic (ROC) curves for hospital mortality of patients affected by severe acute pancreatitis (SAP). Area under the curve (AUC) for discriminating variables at the time of patients' admission to the intensive care unit (ICU). **a***Patients' age* = 0.846 (95 % confidence interval (CI) = 0.7--0.99; *P* = 0.001), **b***Charlson Comorbidity Score* = 0.801 (95 % CI = 0.633--0.968; *P* = 0.003), **c***Ranson criteria* = 0.584 (95 % CI = 0.415--0.753; *P* = 0.405), **d***Glasgow Coma Scale* = 0.56 (95 % CI = 0.394--0.726; *P* = 0.552), **e***Sequential Organ Failure Assessment Score (SOFA)* = 0.537 (95 % CI = 0.363--0.712; *P* = 0.712), **f***Acute Physiologic and Chronic Health Evaluation (APACHE) II score* = 0.509 (95 % CI = 0.334--0.684; *P* = 0.926) (All *P* values are calculated for each variable in comparison to the reference line; AUC = 0.5)

### Risk factors for abdominal compartment syndrome and outcomes of decompressive laparotomy {#Sec18}

Analysis of the clinical and laboratory characteristics of patient who developed ACS and underwent DL revealed that they were more frequently males (*P* = 0.03), had a higher respiratory and heart rate (*P* = 0.008, 0.01), lower systolic blood pressure (*P* = 0.05), and higher serum creatinine levels (*P* = 0.04) at admission to ICU than patients who did not develop ACS (Table [6](#Tab6){ref-type="table"}). Univariate logistic regression analysis found that only serum creatinine was associated with higher probability of developing ACS (OR 1.115; 95 % CI = 1.02--1.219; *P* = 0.017; Table [7](#Tab7){ref-type="table"}). At multivariable regression analysis, after adjusting for the severity of the disease (Ranson, SOFA, APACHE II, Glasgow-Imrie Scores), age, and presence of obesity, only Glasgow-Imrie and APACHE II scores were significant predictors for ACS with OR of 1.221 and 1.143, respectively (Glasgow-Imrie 95 % CI = 1.000--1.493; *P* = 0.05) (APACHE II 95 % CI = 1.012--1.292; *P* = 0.032).Table 6Characteristics of patients requiring decompressive laparotomy versus patients who did not undergo decompressive laparotomyVariableDecompressive laparotomy (*n* = 16)Nondecompressive laparotomy (*n* = 29)*P* valueDemographic Age, year (mean, SD)55.9 (12.9)60.7 (14)0.39 Male gender (no. patients, %)16 (100)20 (68.9)**0.03**Etiology of pancreatitis (no. patients, %) Gallstone7 (43.8)17 (58.6)0.22 Alcohol7 (43.8)6 (20.6) Idiopathic2 (12.5)5 (17.2) Postendoscopic Cholangiopancreatography (ERCP)02 (6.8)Length of overall hospital stay, days (mean, SD)146.2 (148.5)60.9 (65.2)**0.001**Clinical variables at admission to ICU BMI (mean, SD)30.3 (3.7)30.8 (5.8)0.66 Obesity (BMI \> 30) (no. patients, %)10 (62.5)15 (51.7)0.48 Body temperature, Celsius (mean, SD)37.7 (0.8)37.8 (0.7)0.82 Heart rate/min (mean, SD)122.5 (14.3)107.1 (19.4)**0.01** Systolic blood pressure, mmHg (mean, SD)119.4 (21.3)132.5 (18.5)**0.05** Diastolic blood pressure, mmHg (mean, SD)65.4 (15.9)69.5 (12.5)0.37 Respiratory rate/min (mean, SD)27.0 (11.4)16.8 (5.4)**0.008**Laboratory variables at admission to ICU White blood cells, 10^3^/μL (mean, SD)17.7 (5.1)13.8 (5)0.29 Platelets, 10^3^/μL (mean, SD)187.3 (90.6)235.2 (153.4)0.29 Creatinine, μmol/L (mean, SD)292.6 (196.3)187.2 (134.5)**0.04** Glucose, mmol/L (mean, SD)10.7 (3.5)8.2 (4.5)0.08 LDH, U/L (mean, SD)485.0 (348.2)477 (336.3)0.94 AST, U/L (mean, SD)73.2 (36.6)97.5 (84.5)0.32 Arterial pH (mean, SD)7.2 (0.9)7.3 (0.1)0.11 Alveolar arterial gradient (A-a gradient) (mean, SD)346.2 (167.2)264.8 (159.7)0.13 Pulmonary artery oxygen/FiO~2~ ratio (mean, SD)91.3 (25.5)109.3 (63.4)0.33Laboratory variables at 48 h after admission to ICU Serum calcium, mmol/L (mean, SD)2.1 (0.1)2.2 (0.1)0.2 Blood urea nitrogen, mmol/L (mean, SD)13.5 (8.3)13.7 (8.4)0.95 Sequestration of more than 6 L in 48 h (no. patients, %)16 (100)28 (96.5)0.51 Blood urea nitrogen increase at least by 1.8 (no. patients, %)9 (56.2)17 (58.6)0.74 PaO~2~ \<60 mmHg within 48 h (no. patients, %)4 (25)9 (31)0.46 Hematocrit fall \>10 % (no. patients, %)16 (100)26 (89.6)0.3CCI at admission to ICU (mean, SD)2 (1.6)3.2 (2)0.06Severity of acute pancreatitis at admission to ICURanson score system6 (1.8)5.2 (1.6)0.18Glasgow scale9.9 (4.7)8.7 (4.6)0.4APACHE II score (mean, SD)22.6 (6.2)19.4 (6.3)0.13Sequential Organ Failure Assessment (mean, SD)9 (2.9)8.3 (3.1)0.47Time interval between diagnosis of ACS and DL (h) (mean, SD)3.1 (1.7)n.a.--In-hospital mortality (no. patients, %)4 (25)7 (24.1)0.9Bold indicate statistical significant values*ERCP* endoscopic retrograde cholangiopancreatography, *BMI* body mass index, *LDH* lactic dehydrogenase, *AST* aspartate transaminase, *ICU* intensive care unit, *DL* decompressive laparotomy, *ACS* abdominal compartment syndrome, *n.a.* not applicableTable 7Univariate logistic regression: risk factors for abdominal compartment syndromeVariableOR for entire study population (95 % Cl)*P* valueOR for obese patients (95% CI)*P* valueOR for nonobese patients (95 % CI)*P* valueSerum creatinine (μmol/L)1.115 (1.02, 1.219)**0.017**1.005 (0.999, 1.01)0.1031.003 (0.996, 1.009)0.412Respiratory Rate/minute1.004 (1, 1.008)0.0531.071 (0.961, 1.193)0.2131.206 (0.997, 1.46)0.054Age0.968 (0.922, 1.017)0.1950.961 (0.899, 1.028)0.2490.981 (0.911, 1.055)0.597Obesity (BMI \> 30)0.56 (0.161, 1.949)0.362**--------**Charlson Comorbidity score0.79 (0.568, 1.099)0.1620.951 (0.622, 1.453)0.8160.603 (0.327, 1.114)0.106Ranson score1.13 (0.798, 1.601)0.491.166 (0.763, 1.783)0.4780.985 (0.516, 1.878)0.963SOFA score1.079 (0.88, 1.322)0.4651.062 (0.825, 1.369)0.641.039 (0.708, 1.525)0.844APACHE II score1.085 (0.978, 1.204)0.1221.05 (0.929, 1.185)0.4361.163 (0.924, 1.464)0.197Glasgow-Imrie score1.064 (0.911, 1.241)0.4341.148 (0.95, 1.388)0.1520.92 (0.667, 1.268)0.61Bold indicate statistical significant values

Hospital stay for patients who underwent DL was significantly longer (146 vs. 60 days; *P* = 0.001) compared with patients who did not develop ACS, but they did not experience higher mortality rates (25 vs. 24 %; *P* = 0.9). All 16 patients who underwent DL had a temporary abdominal wall closure with either Bogota bag (11 subjects) or wound V.A.C system^®^ (five subjects). Delayed primary closure was performed in 11 patients and split-thickness skin graft was necessary in five. Perioperative complications of DL were significant with ten surgical site infections that ultimately led to eight hernias requiring delayed repair, seven entero-atmospheric fistulas that were managed by late intestinal resections, three wound dehiscences that were fixed surgically, and three pancreatico-atmospheric fistulas that resolved without any further surgical intervention.

ROC curves for the development of ACS showed that there were no clinical or laboratory characteristics with acceptable discrimination (Fig. [2](#Fig2){ref-type="fig"}). Serum creatinine level at admission to ICU and respiratory rate had better discrimination performance with AUC equal to 0.69 and 0.68, respectively, compared with established prognostic models with AUC ranging from 0.58 (Ranson) to 0.66 (APACHE II). Presence of obesity had poor discrimination with AUC = 0.57.Fig. 2Receiver operating characteristic (ROC) curves for the development of abdominal compartment syndrome (ACS) in patients affected by severe acute pancreatitis (SAP). Area under the curve (AUC) for discriminating variables at the time of patients' admission to the intensive care unit (ICU), **a***Serum creatinine* = 0.699 (95 % CI = 0.54--0.858; *P* = 0.028), **b***Respiratory rate* = 0.681 (95 % CI = 0.515--0.847; *P* = 0.046), **c** Acute Physiologic and Chronic Health Evaluation (*APACHE*) *II score* = 0.661 (95 % CI = 0.487--0.835; *P* = 0.07, **d***Glasgow Coma Scale* = 0.584 (95 % CI = 0.394--0.774; *P* = 0.355), **e***Sequential Organ Failure Assessment Score* (*SOFA*) = 0.582 (95 % CI = 0.411--0.753; *P* = 0.368), **f** Obesity (BMI ≥ 30) = 0.571 (95 % CI = 0.396--0.747; *P* = 0.434), **g***Ranson score* = 0.548 (95 % CI = 0.365--0.732; *P* = 0.594) (All *P* values are calculated for each variable in comparison to the reference line; AUC = 0.5)

Discussion {#Sec19}
==========

Obesity, mortality, development of abdominal compartment syndrome and decompressive laparotomy {#Sec20}
----------------------------------------------------------------------------------------------

To our knowledge, this is the first study to compare the outcomes of obese patients admitted to the ICU with SAP versus nonobese individuals. Other authors published outcomes from retrospective cohorts of all patients affected by AP and did not restrict their analysis to those requiring ICU care for SAP \[[@CR19]--[@CR21], [@CR26], [@CR54]--[@CR59]\]. Our study has shown that, in these settings, obesity might be protective for mortality but not for the development of ACS. Because obese patients underwent DL more often than nonobese individuals, their lower mortality is quite provocative, because it seems to conflict with previous studies \[[@CR19]--[@CR21], [@CR24], [@CR26], [@CR54]--[@CR59]\]. Lankisch et al. \[[@CR60]\] were the first to report higher risk of respiratory, renal, and circulatory insufficiency in patients with elevated body weight affected by AP. Several other small studies have subsequently reported a positive correlation between obesity and respiratory failure, local complications, and death \[[@CR20], [@CR54], [@CR55]\]. A recent meta-analysis found a twofold increase in mortality in obese patients with AP \[[@CR21]\]. The mechanisms by which obesity adversely affects the course of AP are still unclear \[[@CR24], [@CR56]\]. Overweight patients have an up-regulated systemic \[[@CR53], [@CR54], [@CR58], [@CR61]\] and local inflammatory response \[[@CR24], [@CR52], [@CR57], [@CR62]\]. They are more frequently immunodeficient \[[@CR61], [@CR62]\] and have larger deposits of retroperitoneal and visceral fat where necrosis and infections frequently occur in AP \[[@CR24], [@CR52], [@CR63], [@CR64]\]. Their pancreatic microcirculation is to some extent compromised by fat deposition in the gland, and the pancreas therefore is more prone to necrosis \[[@CR26]\]. Excessive body weight also reduces the compliance of the chest wall, diaphragm, and abdominal wall with subsequent increased thoracic and peritoneal pressures \[[@CR26]\]. The negative prognostic factor represented by obesity is therefore supported by both biological and clinical observations \[[@CR24]\]. However, there is still controversy on this topic \[[@CR1], [@CR2]\] as the evidence that obese patients experience worse outcome \[[@CR19], [@CR21], [@CR54]--[@CR56]\] has been challenged by several more recent large clinical studies \[[@CR22], [@CR25], [@CR59]\]. Mery et al. \[[@CR61]\] have shown that the distribution of fat in the body might be more important than obesity itself for the modulation of SIRS and the risk of mortality in AP. Recent experimental data suggested that visceral fat produces more inflammatory mediators than subcutaneous fat \[[@CR62]\], and a clinical study has found that only increased visceral fat distribution was a negative predictor of survival in AP \[[@CR61]\].

Prediction of mortality {#Sec21}
-----------------------

In our cohort, the observed mortality was 24 % and not significantly different from other studies that reported a range between 17 and 39 % \[[@CR65]--[@CR67]\]. Compared with the predicted mortality by Ranson and the APACHE II scores, the observed death rate was much lower, although it did not reach statistical significance. There are many possible reasons for the discrepancy between predicted and observed mortality in this study. During the past few decades, significant improvements occurred in the management of MOF patients with SAP \[[@CR1]\], including the introduction of parenteral and enteral nutrition and more effective broad-spectrum antibiotics \[[@CR1], [@CR68]\]. Surgeons also have played an important role in improving the overall outcomes of patients with SAP by being more selective when recommending surgery and by using less invasive procedures for the debridement of necrotic tissue \[[@CR1], [@CR63]\]. As a result, a growing proportion of patients with SAP is now able to overcome both the early systemic inflammatory response syndrome (SIRS) and the second phase of illness characterized by sepsis and organ failure \[[@CR57], [@CR64], [@CR69]--[@CR71]\]. Because of these important changes in the management of patients with SAP, it might be necessary to reevaluate the role of predicting models that were introduced several decades ago \[[@CR5]--[@CR9], [@CR23], [@CR24], [@CR28]--[@CR30], [@CR32], [@CR65], [@CR66], [@CR72]\]. In our study, advanced age and the presence of comorbidities seemed to play a more influential role than any of the well recognized predicting models. Contrary to the results reported by Ueda et al. \[[@CR67]\] who observed that both Ranson and APACHE II scores had good discrimination for mortality with AUC of 0.8, our findings supported the results of other authors \[[@CR58], [@CR68], [@CR73]\], who observed that Ranson score was a relatively poor predictor for in-hospital mortality, whereas age and the presence of comorbidities were better discriminating factors. While the limited sample size may account for some variations, it also is possible that different inclusion criteria might have played an important role as other studies did not include only subjects affected by SAP and requiring ICU admission \[[@CR69]\].

Prediction of abdominal compartment syndrome {#Sec22}
--------------------------------------------

ACS was observed in 35 % of this cohort, similarly to previous studies where 23 \[[@CR74]\] and 56 % \[[@CR75]\] of patients with SAP developed IAH. The clinical relevance of ACS is illustrated by the significantly longer hospital stay compared with those who did not require DL as previously described by Al-Bahrani et al. \[[@CR75]\]. Contrary to our experience, De Waele et al. \[[@CR76]\] not only reported significantly longer ICU and hospital stays in patients with IAH but also an increased mortality. In our study, the mortality rate of patients who developed ACS was 25 %, similar to that observed in patients who did not develop IAH. This might be due to the fact that patients who underwent DL at our institution were taken to the operative room within a very short period as the median time interval from diagnosis to the start of DL was only 3.1 h. The rationale to perform an urgent DL was to restore, as soon as possible, the physiological microcirculatory parameters and avoid further damage to the renal and cardiorespiratory systems \[[@CR77]\]. Although this might be valid for trauma patients, we recognize that there is lack of studies to support this strategy in AP and it is still unknown the optimal time for intervention and the optimal threshold of IAP that would mandate surgical decompression in patients with SAP \[[@CR4], [@CR78], [@CR79]\]. It also is unclear the degree to which IAH contributes to the progression of organ dysfunction in patients with SAP and deteriorating organ function. Mentula et al. \[[@CR77]\] found that patients with IAP exceeding 25 mmHg within the first 4 days after diagnosis of SAP might be good candidates for surgical decompression, but there is need for more studies to support these findings.

Outcomes of decompressive laparotomy {#Sec23}
------------------------------------

Substantial morbidity was associated with DL, and the decision to perform surgery had important clinical implications \[[@CR80]\]. An open abdomen is a well-recognized risk factor for the development of fistulas, intra-abdominal abscesses, abdominal wall infections, and hernias whose management can be very challenging especially in obese patients \[[@CR80]\]. In this study, enterocutaneous or enteroatmospheric fistulas occurred in 43 % of the subjects undergoing DL, 18 % required the use of split-thickness skin graft for the closure of their incision, and 50 % developed incisional hernias that required delayed repair \[[@CR81]\]. Overall, 85 % of patients undergoing DL needed at least another surgical intervention for the management of their open abdomen, and compared with patients treated by conservative measures and who survived, their hospital stay was approximately 2 months longer.

Predictive models {#Sec24}
-----------------

Contrary to other authors \[[@CR41], [@CR76], [@CR77]\], we did not identify any significant difference between the values of predicting scores in patients who underwent DL and the group treated conservatively. We also failed to identify any variable that could classify patients at risk of developing ACS as the discriminating performance of all the severity scoring systems, such as APACHE II, SOFA, Ranson, Glasgow-Imrie, and other predictors, including BMI had ROC curves with AUC ranging only between 0.54 and 0.69. Dambrauskas et al. \[[@CR41]\] observed good discriminating characteristics for APACHE II (AUC of 0.86) and for Glasgow-Imrie score (AUC of 0.92). In their study, APACHE II cutoff of seven had a sensitivity of 100 % and specificity of 60 % for the diagnosis of ACS. Similarly, Glasgow-Imrie score greater than three had a sensitivity of 83 % and specificity of 86 %. Several factors may explain these variations as the inclusion and exclusion criteria were different and the proportion of patients with obesity was not specified. Therefore, interpreting and comparing the results is difficult considering the heterogeneity of patient populations, methods, and outcome reporting among all the various publications \[[@CR11]\].

Strengths and limitations {#Sec25}
-------------------------

One of the strengths of this study is that it is the largest experience of patients affected by SAP as defined by the Atlanta consensus conference and admitted in ICU at a tertiary teaching center. Another important aspect is that strict inclusion and exclusion criteria were applied and that a power calculation was performed to assess the number of subjects needed to identify possible differences for the primary outcome between groups. Lastly, established and clear definitions were used for the description of the study population, clinical investigations, and surgical interventions necessary for comparison with other studies.

Our study has several limitations due to its retrospective design. During the time period of this study, there were no protocols or established algorithms specific to our institution for the management of patients affected by SAP. This led to variations on the decision-making process among all the physicians practicing in our ICU. As a consequence, SAP patients did not undergo routine measurements of their abdominal pressure unless they manifested deterioration of their cardiopulmonary or renal function. The decision to perform DL also was made selectively by the surgeon staff on call once notified of the clinical deterioration of the patient or the elevated value of the intra-abdominal pressure after conservative measures, such as the use of paralyzing agents and/or aggressive diuresis failed \[[@CR39]\]. Because there is still no uniform consensus in the literature on the indications for surgical decompression in ACS associated with SAP \[[@CR40], [@CR74]\], it is very likely that in many circumstances the value of intra-abdominal pressure was not the only parameter used for the decision to perform a DL. It is possible that in this cohort some patients might have developed ACS, which likely a rare event because the overall mortality of our study population was comparable to that reported by other investigators who recommend routine measurement of the intra-abdominal pressures in all patients admitted in ICU for SAP \[[@CR59], [@CR82]\].

Conclusions {#Sec26}
===========

Mortality of patients with SAP has declined significantly during the past few decades despite the increasing number of obese patients in the general population. This study suggests that obesity per se is not a negative prognostic factor for mortality in patients with SAP admitted to the ICU. DL is associated with higher rates of fistulization and required multiple surgical interventions for the management of the open abdomen. Nevertheless, mortality rate of patients undergoing DL was similar to patients who did not require surgery suggesting that, in selected patients, DL might have a significant role in reversing the declining course of SAP. Because most of the current literature is retrospective and from the experience of single-centers with limited number of patients, prospective studies are necessary to assess the impact of obesity, fat distribution, and other variables, such as age or comorbidities, on mortality and morbidity of patients with SAP requiring ICU admission.
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